The sale of Walgreens home infusion business to a private equity firm will give Walgreens the chance to double down on the growing market. Announced Jan. 20, Madison Dearborn Partners, a Chicago-based private equity firm, will acquire a 51% majority stake in Walgreens Infusion Services. The firm will take the company private, according to a release. Walgreens entered the home infusion space when it acquired OptionCare for $850 million in 2007. It traded its long-term care pharmacy business for OmniCare’s home infusion business in 2010, making it the largest provider in the space.
Market Pulse transactions shown herein are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within the healthcare and life sciences sectors.